Clinical Trials Browser

Phase 1/2 × TNBC × 130-nm albumin-bound paclitaxel × Clear all

NCT05918133 2025-03-11

A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC

Phase 1/2 Active not recruiting

TNBC